From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: My £5 bet with Cliff Weight of ShareSoc

By Tom Winnifrith | Tuesday 10 May 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Cliff admits he will lose, so has decently added £5 to his Rogue Bloggers for Woodlarks donation. Why not join him? Leave the 96% of listeners yet to donate, and chip in today, HERE. The bet is on Zephyr Energy (ZPHR), where Cliff is long (and wrong). I offer him the chance to double up with a bet on Wildcat Petroleum (WCAT), following its bonkers RNS yesterday. But I think he is too smart to take that. I also look at Versarien (VRS), Eden Research (EDEN), Kefi (KEFI), and Amur Minerals (AMC), on a day of water triumph at the Greek Hovel. How I wish I was there.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:51:22